Status:
UNKNOWN
Zinc Supplementation on Very Low Birth Weight Infant
Lead Sponsor:
Fakultas Kedokteran Universitas Indonesia
Conditions:
Early-Onset Sepses, Neonatal
Periventricular Haemorrhage Neonatal
Eligibility:
All Genders
Up to 3 years
Phase:
PHASE4
Brief Summary
Premature birth is a major cause of neonatal death in addition to neonatal asphyxia and infections. Early in life, premature babies must get aggressive nutrition so that there is no extrauterine grow...
Detailed Description
Double-blind randomized controlled clinical trial in preterm infants (28 - 32 weeks) who are newborn or less than 3 days old who are admitted to the perinatology room. Infant in the intervention grou...
Eligibility Criteria
Inclusion
- Preterm (gestational age of 28 - 32 weeks)
- Newborns with a ratio of body weight and gestational age: Small for Gestational Age or Large for Gestational Age
- Get parental approval to be included in the study by signing an informed consent
Exclusion
- Newborns with severe congenital abnormalities
- Newborns with digestive tract abnormalities: partial, total obstruction or gastrointestinal atresia
- Newborns with unstable hemodynamic conditions that will affect the survival rate
- Mothers who consume alcohol regularly (≧ 2x a month) during pregnancy
- Newborns with early-onset sepsis
Key Trial Info
Start Date :
August 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2020
Estimated Enrollment :
364 Patients enrolled
Trial Details
Trial ID
NCT04050488
Start Date
August 20 2019
End Date
July 31 2020
Last Update
August 15 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.